Pay in 4 interest-free payments of $6.82 Learn more
Ships within 48 hours · Estimated delivery Aug 22 - Aug 27
Pramlintide is an amylin analogue licensed for type 1 diabetes in the US but currently very few people are treated with it [4], and the risk of severe hypoglycaemia remains a barrier to its approval in the UK and Europe [5]
doi:10.1076/opep.10.4.215.15906
Adding GIP (the dual-agonist tirzepatide step) meaningfully amplifies the satiety and adipose-tissue effects beyond what GLP-1-only molecules achieve, despite earlier scepticism that GIP signalling was non-functional in type-2 diabetes
doi:10.3390/metabo13010125 4
US$ 27.17
US$ 26.00
US$ 29.50
US$ 26.74
US$ 23.39
US$ 24.24
US$ 28.45
